Vol 25, No 1 (2022)

Date published: 2022-01-31

Table of Contents

open access

Editorial

Editorial Note

Grzegorz Kamiński

Editorial

DOI: 10.5603/NMR.2022.0001
Nucl. Med. Rev 2022;25(1).
Original articles

Sensitivity of [18F]FDG PET/CT and classification of the primary tumor site in patients with carcinoma of unknown primary

Hasan Ikbal Atilgan, Hulya Yalcin

Research paper

DOI: 10.5603/NMR.a2022.0002
Pubmed: 35137930
Nucl. Med. Rev 2022;25(1):1-5.

Assessing the correlation between FDG PET findings of IDC breast carcinoma and histopathology of coexisting ductal carcinoma in-situ

Ismet Sarikaya, Ali Sarikaya, Ahmed N. Albatineh, Ebru Tastekin, Yavuz Atakan Sezer

Research paper

DOI: 10.5603/NMR.a2022.0003
Pubmed: 35137931
Nucl. Med. Rev 2022;25(1):6-11.

Degree of agreement between dacryoscintigraphy and dacryocystography examinations results in primary acquired nasolacrimal duct obstruction

Elyas Aditya, Yunia Irawati, Benny Zulkarnaien, Joedo Prihartono

Research paper

DOI: 10.5603/NMR.a2022.0004
Pubmed: 35137932
Nucl. Med. Rev 2022;25(1):12-17.

Relationship between cerebral blood flow reduction patterns on scintigraphy and nonmotor symptoms in new-onset Lewy body disease

Yukinori Okada, Makoto Shiraishi, Koji Hori, Keiichro Yamaguchi, Yasuhiro Hasegawa

Research paper

DOI: 10.5603/NMR.a2022.0005
Pubmed: 35137933
Nucl. Med. Rev 2022;25(1):18-24.

Detection of a second primary cancer in a 18F-fluorocholine PET/CT – multicentre retrospective analysis on a group of 1345 prostate cancer patients

Paulina Cegla, Katarzyna Scibisz-Dziedzic, Kamila Witkowska, Anna Kubiak, Ewa Wierzchoslawska, Witold Kycler, Beata Chrapko, Rafał Czepczyński

Research paper

DOI: 10.5603/NMR.a2022.0006
Pubmed: 35137934
Nucl. Med. Rev 2022;25(1):25-30.

The efficacy of melatonin against radiotoxicity of iodine-131 and its response to treatment in hyperthyroid patients: a randomized controlled trial

Soudabe Alidadi, Ali Shabestani Monfared, Mehrangiz Amiri, Ebrahim Zabihi, Ehsan Assadollahi, Amir Gholami, Zoleika Moazezi, Zeinab Abedian

Research paper

DOI: 10.5603/NMR.a2022.0007
Pubmed: 35137935
Nucl. Med. Rev 2022;25(1):31-36.

Optimized method for normal range estimation of standardized uptake values (SUVmax, SUVmean) in liver SPECT/CT images with somatostatin analog [99mTc]-HYNIC-TOC (Tektrotyd)

Hanna Piwowarska-Bilska, Sara Kurkowska, Bozena Birkenfeld

Research paper

DOI: 10.5603/NMR.a2022.0008
Pubmed: 35137936
Nucl. Med. Rev 2022;25(1):37-46.

Optimal activity of [18F]FDG for Hodgkin lymphoma imaging performed on PET/CT camera with BGO crystals

Miroslaw Dziuk, Ewa Witkowska-Patena, Agnieszka Gizewska, Andrzej Mazurek, Anna Pieczonka, Magdalena Koza, Marina Gerszewska, Zbigniew Podgajny, Marta Chojnowska

Research paper

DOI: 10.5603/NMR.a2022.0009
Pubmed: 35137937
Nucl. Med. Rev 2022;25(1):47-53.

Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm

Barbara Bober, Marek Saracyn, Arkadiusz Lubas, Maciej Kolodziej, Dorota Brodowska-Kania, Waldemar Kapusta, Grzegorz Kaminski

Research paper

DOI: 10.5603/NMR.a2022.0016
Pubmed: 35137938
Nucl. Med. Rev 2022;25(1):54-61.
Clinical vignette

Efficacy of long-term ultrasonography in follow-up of patients with papillary thyroid carcinoma: a case of neck metastasis developed 19 years following primary treatment

Vlatka Jozanovic, Sanja Kusacic Kuna, Marija Despot, Tatjana Samardzic, Drazen Huic

Clinical vignette

DOI: 10.5603/NMR.a2022.0011
Pubmed: 35137939
Nucl. Med. Rev 2022;25(1):62-63.

Different glucose metabolism behavior relating to histotypes in synchronous breast cancers evaluated by [18F]FDG PET-CT

Pietro Bellini, Domenico Albano, Francesco Dondi, Francesco Bertagna, Raffaele Giubbini

Clinical vignette

DOI: 10.5603/NMR.a2022.0012
Pubmed: 35137940
Nucl. Med. Rev 2022;25(1):64-65.

Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism

Vlatka Jozanovic, Drazen Huic

Clinical vignette

DOI: 10.5603/NMR.a2022.0013
Pubmed: 35137941
Nucl. Med. Rev 2022;25(1):66-67.

Rare osteoarticular complications on [18F]FDG-PET/CT — following intravesical BCG immunotherapy for bladder cancer

Jan-Henning Schierz, Anke McLeod, Farzana Ali

Clinical vignette

DOI: 10.5603/NMR.a2022.0014
Pubmed: 35137942
Nucl. Med. Rev 2022;25(1):68-69.

Hybrid bone SPECT/CT reveals spleen calcification in sickle cell mutation and beta-thalassemia

Konstantinos Sakellariou, Sofia Charalampidou, Andreas Fotopoulos, Chrissa Sioka

Clinical vignette

DOI: 10.5603/NMR.a2021.0015
Pubmed: 35137943
Nucl. Med. Rev 2022;25(1):70-71.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl